Quest Diagnostics: Q3 Earnings Insights
Quest Diagnostics (NYSE:DGX) reported its Q3 earnings results on Thursday, October 20, 2022 at 06:45 AM.
Here's what investors need to…
163,711$
-0,11%
Echtzeit-Aktienkurs Quest Diagnostics
Bid:
Ask:
Nachrichten zur Quest Diagnostics Aktie
Form 8-K QUEST DIAGNOSTICS INC For: Oct 20
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Quest Diagnostics Reports Third Quarter 2022 Financial Results; Raises Guidance for Full Year 2022
Third quarter revenues of $2.49 billion, down 10.4% from 2021 Third quarter reported diluted earnings per share ("EPS") of $2.17,…
Quest Diagnostics Non-GAAP EPS of $2.36 beats by $0.18, revenue of $2.49B beats by $150M, raises FY22 guidance
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Quest Diagnostics Q3 2022 Earnings Preview
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Decode Health Collaborates with Quest Diagnostics to Speed Biomarker Discovery for Drug and Diagnostics Development
Features Nationally Scaled RNA Sequencing and Specimen Collection for Multiple Sclerosis and Non-Alcoholic Fatty Liver Disease with Plans to Expand…
Quest Encourages Consumers to "Put Your ____ To The Test" in Bold and Disruptive New Ad Campaign
SECAUCUS, N.J., Oct. 13, 2022 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the leader in diagnostic testing, unveiled a nationwide campaign,…
Quest Diagnostics Announces Organizational Changes to Accelerate Growth and Drive Operational Excellence
SECAUCUS, N.J., Oct. 13, 2022 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the worlds leading provider of diagnostic information services, today…
Should Value Investors Buy Quest Diagnostics (DGX) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to…
Breast and Prostate Cancer Diagnoses Still Lagging During Second Full Year of COVID-19 Pandemic, Quest Diagnostics Health Trends® Study Finds
Analysis of more than 1.1 million test results across the United States suggests more people are living with undiagnosed cancer…
Global Point of Care Testing Market Research Report 2022-2028 with Competitive Profiles of 100 Key Players Including Abbott, Siemens Healthineers, Roche Diagnostics, Quest Diagnostics, BD and Co
DUBLIN, Oct. 6, 2022 /PRNewswire/ -- The "Global Point of Care Testing Market (By Diagnostics Segment, Mode, End Users, Regions),…
Quest To Buy Outreach Lab Services Business Of Summa Health For Undisclosed Terms
WASHINGTON (dpa-AFX) - Quest Diagnostics (DGX), a provider of diagnostic information services, and Summa Health, a large integrated healthcare delivery…
Quest Diagnostics to acquire select assets of Summa Health
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Quest Diagnostics to Acquire Outreach Lab Services Business of Summa Health
Transaction to broaden access to innovative, quality diagnostic information services powering affordable care in Ohio SECAUCUS, N.J., and AKRON, Ohio,…
XFRA : DIVIDEND/INTEREST INFORMATION - 03.10.2022 - US74834L1008
Das Instrument QDI US74834L1008 QUEST DIAGNOSTICS DL-,01 EQUITY wird ex Dividende/Zinsen gehandelt am 03.10.2022
The instrument QDI US74834L1008 QUEST DIAGNOSTICS…